Recurrent Erysipelas: 47 Cases
Posted: Thu Jan 04, 2007 12:44 amRecurrent Erysipelas: 47 Cases
Jan 2007
S. Leclerca, b, A. Teixeiraa, E. Mahéb, V. Descampsb, B. Crickxb, O. Chosidowa
aDepartment of Internal Medicine, Hôpital de la Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie-Paris 6,
bDepartment of Dermatology, Hôpital Bichat-Claude-Bernard, Université Paris VII, Paris, France
Address of Corresponding Author
Dermatology 2007;214:52-57 (DOI: 10.1159/000096913)
Key Words
Antibiotic prophylaxis
Erysipelas
Cellulitis
Abstract
Background:Recurrence is a common complication of erysipelas (cellulitis). Objectives:Todescribe the characteristics of patients with recurrent erysipelas and thereby, identify potential risk factors and evaluate prophylaxis efficacy. Methods:Data were retrospectively recorded from the files of 47 patients admitted to hospital between 1995 and 2003 for erysipelas recurrence. Studied variables included: general condition, regional and local factors, e.g. broken cutaneous barrier. Patient characteristics were used to construct tree-based models according to the classification and regression tree methodology. Results: Our patients suffered a mean of 4.1 recurrences. Cutaneous barrier disruption was observed in 81%, mainly intertrigo (60%). Antibiotic prophylaxis was taken by 68% of the patients for 30.6 months. After 1 and 2 years, 84 and 72% of the patients, respectively, were recurrence-free. Conclusion: Our results showed that erysipelas recurrence has the same risk factors as single episodes and underlines the potential benefit of oral or parenteral antibiotic prophylaxis to prevent recurrences.
Author Contacts
Olivier Chosidow
Department of Dermatology and Allergology, Hôpital Tenon
4 rue de la Chine, FR-75020 Paris (France)
Tel. +33 1 56 01 76 72, Fax +33 1 56 01 64 58
E-Mail olivier.chosidow@tnn.aphp.fr
http://content.karger.com/produktedb/pr ... =000096913
* * * * *
Lymphedema People
http://www.lymphedemapeople.com
Jan 2007
S. Leclerca, b, A. Teixeiraa, E. Mahéb, V. Descampsb, B. Crickxb, O. Chosidowa
aDepartment of Internal Medicine, Hôpital de la Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie-Paris 6,
bDepartment of Dermatology, Hôpital Bichat-Claude-Bernard, Université Paris VII, Paris, France
Address of Corresponding Author
Dermatology 2007;214:52-57 (DOI: 10.1159/000096913)
Key Words
Antibiotic prophylaxis
Erysipelas
Cellulitis
Abstract
Background:Recurrence is a common complication of erysipelas (cellulitis). Objectives:Todescribe the characteristics of patients with recurrent erysipelas and thereby, identify potential risk factors and evaluate prophylaxis efficacy. Methods:Data were retrospectively recorded from the files of 47 patients admitted to hospital between 1995 and 2003 for erysipelas recurrence. Studied variables included: general condition, regional and local factors, e.g. broken cutaneous barrier. Patient characteristics were used to construct tree-based models according to the classification and regression tree methodology. Results: Our patients suffered a mean of 4.1 recurrences. Cutaneous barrier disruption was observed in 81%, mainly intertrigo (60%). Antibiotic prophylaxis was taken by 68% of the patients for 30.6 months. After 1 and 2 years, 84 and 72% of the patients, respectively, were recurrence-free. Conclusion: Our results showed that erysipelas recurrence has the same risk factors as single episodes and underlines the potential benefit of oral or parenteral antibiotic prophylaxis to prevent recurrences.
Author Contacts
Olivier Chosidow
Department of Dermatology and Allergology, Hôpital Tenon
4 rue de la Chine, FR-75020 Paris (France)
Tel. +33 1 56 01 76 72, Fax +33 1 56 01 64 58
E-Mail olivier.chosidow@tnn.aphp.fr
http://content.karger.com/produktedb/pr ... =000096913
* * * * *
Lymphedema People
http://www.lymphedemapeople.com